SELLAS Life Sciences (SLS) Change in Acquisitions & Divestments (2013)
SELLAS Life Sciences' (SLS) quarterly Change in Acquisitions & Divestments came in at $2.5 million in Q4 2013, up 209.46% on a QoQ basis from $814000.0 in Q3 2013.
SELLAS Life Sciences (SLS) Change in Acquisitions & Divestments (2013) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q4 2013.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $2.5 million in Q4 2013; TTM through Dec 2014 was $3.3 million, a 0.0% change from a year earlier, with the FY2013 full-year figure at $3.9 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q4 2013 stood at $2.5 million, up from $814000.0 in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for SLS reached as high as $2.5 million in Q4 2013 and fell as low as $814000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - |
| 10 | SELLAS Life Sciences | 1.97 Bn | 1.86 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 2.52 Mn |
| Dec 31, 2013 | 2.52 Mn |
| Sep 30, 2013 | 814,000.00 |
| Sep 30, 2013 | 814,000.00 |